The European Society for Translational Medicine (EUSTM) cordially invites you to attend the 7th Annual Congress of the European Society for Translational Medicine on Hematologic Malignancies (EUSTM-2020) from 3-4 November, 2020 in Budapest, Hungary.
Hematologic Malignancies are one of the major causes of mortality among oncology patients populations both in developing and developed countries. Hematologic Malignancies, as being one of the main focus areas for EUSTM activities (2020-2022), we are glad to announce that EUSTM-2020 congress will exclusively discuss and address blood cancer theme. EUSTM-2020 will unite the world leaders and experts from academia, research institutions, industry and policy makers to discuss latest findings, advancement and approaches designed to better understand molecular biology and to accelerate diagnostics and therapeutics for acute leukemias (ALL & AML), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), multiple myeloma, hodgkin & non-hodgkin lymphoma, myeloproliferative neoplasms, Myelodysplastic Syndromes (MDS) and other related disorders in blood cancer field.
We look forward to welcome you in Budapest.